BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7013181)

  • 1. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
    García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
    Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
    [No Abstract]   [Full Text] [Related]  

  • 3. Preexistent anti-HLA-DR antibodies and kidney graft survival.
    Sirchia G; Mercuriali F; Scalamogna M; Rosso di San Secondo V; Pizzi C; Poli F; Fortis C; Greppi N
    Transplant Proc; 1979 Mar; 11(1):950-3. PubMed ID: 377727
    [No Abstract]   [Full Text] [Related]  

  • 4. The positive B-cell cross-match: a marker of active enhancement?
    d'Apice AJ; Tait BD
    Transplant Proc; 1979 Mar; 11(1):954-7. PubMed ID: 377728
    [No Abstract]   [Full Text] [Related]  

  • 5. DRw antigen matching and B-cell antibody crossmatching: their effect on clinical outcome of renal transplants.
    Cross DE; Coxe-Gilliland R; Weaver P
    Transplant Proc; 1979 Dec; 11(4):1908-10. PubMed ID: 394436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 8. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 9. Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single center.
    Coxe-Gilliland R; Cross DE
    Transplant Proc; 1981 Mar; 13(1 Pt 2):945-8. PubMed ID: 7022967
    [No Abstract]   [Full Text] [Related]  

  • 10. Serologic considerations in donor-specific transfusion therapy for kidney transplantation.
    Schweizer R; Bow L; Generas D; Bartus S
    Transplant Proc; 1982 Jun; 14(2):374-7. PubMed ID: 6810522
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute rejection of renal allografts with antithymocyte globulin or high-dosage prednisone. Influence of recipient DRw6 and DR matching.
    Hoitsma AJ; Van Lier HJ; Reekers P; Koene RA
    Neth J Med; 1985; 28(6):239-42. PubMed ID: 3892324
    [No Abstract]   [Full Text] [Related]  

  • 12. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of HLA-A, -B and -DR matching in presensitized kidney transplant recipients.
    Busson M; Hors J; Prevost P; Raffoux C; Betuel H; Bignon JD; Tongio MM; Seignalet J; Calot M; Lepetit JC
    Clin Transpl; 1988; ():199-202. PubMed ID: 3154473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.
    Berg B; Möller E
    Scand J Urol Nephrol Suppl; 1980; 54():36. PubMed ID: 7013039
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
    Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of HLA-A, B, C, D, and DR matching in renal transplantation.
    Albrechtsen D; Moen T; Flatmark A; Halvorsen S; Jakobsen A; Jervell J; Solheim BG; Thorsby E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):924-9. PubMed ID: 7022962
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced kidney allograft survival across a positive crossmatch (Cx) arising from B-cell specific and cold reactive antibodies (Ab).
    Lobo P; Rudolf L; Westervelt FB
    Proc Clin Dial Transplant Forum; 1977; 7():4-6. PubMed ID: 356038
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of HLA DR in renal transplantation.
    Fotino M; Suthanthiran M
    N Y State J Med; 1982 Mar; 82(3):327-32. PubMed ID: 7045739
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilutions and specificity analysis of pretransplant sera.
    Iwaki Y; Terasaki PI; Park MS; Heintz R; Silberman H; Berne T
    Transplant Proc; 1979 Mar; 11(1):944-9. PubMed ID: 377726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.